References
- Bocker R. Rapid analysis of hexobarbital and its metabolites in mice by high performance liquid chromatography. Journal of Chromatography 1982; 228: 350–354
- Buchman A., Schwartz M., Schmitt R., Wolf C. R. Development of cytochrome P-450 altered preneoplastic and neoplastic lesions during nitrosamine-induced hepatocarcinogenesis in the rat. Cancer Research 1987; 47: 2911–2918
- Buchman A., Kuhlmann W., Schwarz M., Kunz W. Regulation and expression of four cytochrome P450-isozymes, NADPH-cytochrome P-450 reductase, the glutathione S-transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis 1985; 6: 513–521
- Cooper J. R., Brodie B. B. The enzymatic metabolism of hexobarbital. Journal of Pharmacology and Experimental Therapeutics 1955; 114: 409–417
- Fujino T., West D., Park S. S., Gelboin H. V. Monoclonal antibody-directed phenotyping of cytochrome P-450 dependent aryl hydrocarbon hydroxylase and 7-ethoxy-coumarin deethylase in mammalian tissues. Journal of Biological Chemistry 1984; 259: 9044–9050
- Gelboin H. V. Benzo(a)pyrene metabolism, activation and carcinogenesis: role and regulation of mixed function oxidases and related enzymes. Physiological Review 1980; 60: 1107–1166
- Greenlee W. F., Poland A. An improved assay of 7-ethoxycoumarin-o-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and -tetrachlorodibenzo-p-dioxin. Journal of Pharmacology and Experimental Therapeutics 1978; 205: 596–605
- International Agency for Research on Cancer. IARC monograph on the evaluation of the carcinogen risk of chemicals to human. IARC, LyonFrance 1979; 17, 41, Supplement 1.
- International Agency for Research on Cancer. IARC monograph on the evaluation of the carcinogen risk of chemicals to human. IARC, LyonFrance 1977; Vol. 13: 201–225
- Jin H. S., Won S. M., Lee M. G., Park S. S., Gelboin H. V., Kim N. D. Phenotyping of phenytoin treated rat liver cytochrome P-450 with monoclonal antibodies. Korean Journal of Toxicology 1991; 7: 1–12
- Kutt H., Haynes J., Verebely K., McDowell F. The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver metabolism. Neurology 1969; 19: 611–616
- Kutt H., Verebely K. Metabolism of diphenylhydantoin by rat liver microsomes-I. Biochemical Pharmacology 1970; 19: 675–686
- Laemmli U. K. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 1970; 227: 682–685
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- Nebert D. E., Nelson D. R., Coon M. J., Estabrook R. W., Feyereisen R., Fujii-Kuriyama Y., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Loper J. C., Sato R., Waterman M. R., Waxman D. J. The P450 superfamily: update on new sequences. gene mapping, and recommended nomenclature. DNA and Cell Biology 1991; 10: 1–14
- Omura T., Sato R. The carbon monooxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
- Park S. S., Fujino T., Miller H., Guengerich F. P., Gelboin H. V. Monoclonal antibodies to phenobarbital-induced rat liver cytochrome P-450. Biochemical Pharmacology 1984; 33: 2071–2081
- Reinke L. A., Sexter S. H., Rikans L. E. Comparison of ethanol and imidazole pretreatments on hepatic monooxygenase activities in the rat. Research Communications in Chemical Pathology and Pharmacology 1985; 47: 97–106
- Volk B., Amelizad Z., Anagnostopoulos J., Knoth R., Oesch F. First evidence of cytochrome P-450 induction in the mouse brain by phenytoin. Neuroscience Letters 1988; 84: 219–224